These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 32033229)

  • 81. 2,3-Dimercaptopropanol, 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase lead-induced inhibition of delta-aminolevulinate dehydratase in vitro and ex vivo.
    Santos FW; Rocha JB; Nogueira CW
    Toxicol In Vitro; 2006 Apr; 20(3):317-23. PubMed ID: 16168622
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Toxicity of inorganic arsenic to animals and its treatment strategies.
    Su Q; He Y; Pan H; Liu H; Mehmood K; Tang Z; Hu L
    Comp Biochem Physiol C Toxicol Pharmacol; 2023 Sep; 271():109654. PubMed ID: 37230210
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effects of some thiol chelators on enzymatic activities in blood, liver and kidneys of acute arsenic (III) exposed mice.
    Tripathi N; Flora SJ
    Biomed Environ Sci; 1998 Mar; 11(1):38-45. PubMed ID: 9559101
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Combination therapy with vitamin C and DMSA for arsenic-fluoride co-exposure in rats.
    Mittal M; Chatterjee S; Flora SJS
    Metallomics; 2018 Sep; 10(9):1291-1306. PubMed ID: 30140832
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Unithiol and mecaptid as antidotes in poisoning with arsenic-containing substances].
    Miziukova IG; Petrun'kin VE
    Vrach Delo; 1974 Feb; (2):126-9. PubMed ID: 4468608
    [No Abstract]   [Full Text] [Related]  

  • 86. Comparison of the effectiveness of 2,3-dimercaptopropanol (BAL) and meso-2,3-dimercaptosuccinic acid (DMSA) as protective agents against mercuric chloride-induced nephrotoxicity in rats.
    de la Torre A; Bellés M; Llobet JM; Mayayo E; Domingo JL
    Biol Trace Elem Res; 1998 Jul; 63(1):1-10. PubMed ID: 9764565
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Co-administration of meso 2,3-dimercaptosuccinic acid monoesters reduces arsenic concentration and oxidative stress in gallium arsenide exposed rats.
    Flora SJ; Bhatt K; Dwivedi N; Pachauri V; Kushwah PK
    Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):423-9. PubMed ID: 21501211
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Chronic arsenic toxicity: clinical features, epidemiology, and treatment: experience in West Bengal.
    Guha Mazumder DN
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2003 Jan; 38(1):141-63. PubMed ID: 12635824
    [TBL] [Abstract][Full Text] [Related]  

  • 89. In vivo screening of potential antidotes for chronic cadmium intoxication.
    Shinobu LA; Jones MM; Basinger MA; Mitchell WM; Wendel D; Razzuk A
    J Toxicol Environ Health; 1983; 12(4-6):757-65. PubMed ID: 6321748
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Monoisoamyl 2, 3-dimercaptosuccinic acid (MiADMSA) demonstrates higher efficacy by oral route in reversing arsenic toxicity: a pharmacokinetic approach.
    Flora SJ; Bhadauria S; Pachauri V; Yadav A
    Basic Clin Pharmacol Toxicol; 2012 May; 110(5):449-59. PubMed ID: 22117535
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Structural requirements for chelate antidotal efficacy in acute antimony(III) intoxication.
    Basinger MA; Jones MM
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):355-63. PubMed ID: 6264554
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Combinatorial drug delivery strategy employing nano-curcumin and nano-MiADMSA for the treatment of arsenic intoxication in mouse.
    Kushwaha P; Yadav A; Samim M; Flora SJS
    Chem Biol Interact; 2018 Apr; 286():78-87. PubMed ID: 29548727
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Chelation therapy in intoxications with mercury, lead and copper.
    Cao Y; Skaug MA; Andersen O; Aaseth J
    J Trace Elem Med Biol; 2015; 31():188-92. PubMed ID: 24894443
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Antidotal efficacy of newly synthesized dimercaptosuccinic acid (DMSA) monoesters in experimental arsenic poisoning in mice.
    Kreppel H; Reichl FX; Kleine A; Szinicz L; Singh PK; Jones MM
    Fundam Appl Toxicol; 1995 Jul; 26(2):239-45. PubMed ID: 7589912
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [BAL therapy of chronic arsenic poisoning from drinking water].
    ZINNY M; BERLANGA R; MENDIZABAL J
    Prensa Med Argent; 1951 Sep; 38(37):2378-80. PubMed ID: 14883106
    [No Abstract]   [Full Text] [Related]  

  • 96. [Molecular mechanism of action of dithiols].
    Trinus FP; Braber-Chernobul'skaia BS; Chubenko AV; Luĭk AI; Grigor'eva AS
    Vestn Akad Med Nauk SSSR; 1984; (11):75-84. PubMed ID: 6152101
    [No Abstract]   [Full Text] [Related]  

  • 97. Acute arsenic exposure secondary to deliberate self-poisoning with sheep dip.
    Hodgson S; Abouchedid R; Cleary K; Tile N; Wong A
    Am J Emerg Med; 2024 Jun; 80():226.e1-226.e3. PubMed ID: 38702220
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Unusual presentation of arsenic poisoning in a case of celiac disease.
    Hasanato RM; Almomen AM
    Ann Saudi Med; 2015; 35(2):165-7. PubMed ID: 26336025
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Therapeutic profile of T11TS vs. T11TS+MiADMSA: a hunt for a more effective therapeutic regimen for arsenic exposure.
    Chaudhuri S; Acharya S; Chatterjee S; Kumar P; Singh MK; Bhattacharya D; Basu AK; Dasgupta S; Flora SJ; Chaudhuri S
    Asian Pac J Cancer Prev; 2012; 13(6):2943-8. PubMed ID: 22938487
    [TBL] [Abstract][Full Text] [Related]  

  • 100. 2,3-Dimercapto-1-propanesulphonate in heavy metal poisoning.
    Hruby K; Donner A
    Med Toxicol Adverse Drug Exp; 1987; 2(5):317-23. PubMed ID: 3312928
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.